$OCUL

Ocular Therapeutix Inc

$OCUL

Ocular Therapeutix Inc

Past 12mo:17mentions1voices

All voices4 calls since Jan 2026show all

Loading price chart…

Recent calls

4 calls

@adamfeuersteinMar 20, 2026 · 8:40 PM

$EYPT suing $OCUL. https://t.co/DnnPnqRLKJ

Open on X

@adamfeuersteinFeb 17, 2026 · 2:49 PM

@toplvl_excutive @houmanhemmati Agreed. As I said earlier, $OCUL modeled Axpaxli durability very well, but not so with low dose Eylea. The risk of this unconventional study design may not pay off.

Open on X

@adamfeuersteinFeb 5, 2026 · 6:53 PM

I received a strongly worded statement from $OCUL “The rumors that are circulating alleging that we have seen the unmasked results from the SOL-1 trial or have knowledge that the trial did not succeed are categorically false." More in the story...

Open on X

@adamfeuersteinJan 8, 2026 · 3:03 PM

This week's Biotech Scorecard newsletter: Ocular Therapeutix $OCUL faces looming test of a more durable eye treatment. A preview of the Axpaxli SOL-1 clinical trial readout expected in February https://t.co/XTI2wySnbB

Open on X

Frequently asked

Who mentions $OCUL most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $OCUL most — 17 mentions in the past 12 months.

When was $OCUL first mentioned on Surfaced?

The earliest tracked mention of $OCUL in the Surfaced archive was on Dec 19, 2025.

How many voices track $OCUL?

1 FinTwit voice has mentioned $OCUL 17 times in the past 12 months.

What kind of voices mention $OCUL most?

$OCUL is mentioned most by Biotech voices on Surfaced.